Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 1/2 1

Status

Completed 4

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 3Head & Neck 1Gynecologic 1Genitourinary 1

Conditions

Colorectal Neoplasms 2Urinary Bladder Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Recurrent Platinum Resistant Ovarian Cancer 1Rectal Neoplasms 1Neoplasm Metastasis 1Carcinoma 1Adenoviridae Infections 1

Interventions

Cyclophosphamide 1499Cisplatin 1435Paclitaxel 1340Radiotherapy 1310Carboplatin 1267Gemcitabine 1226Docetaxel 1133Bevacizumab 1070Fluorouracil 906Doxorubicin 805Dexamethasone 755Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 700Etoposide 679Irinotecan 639Filgrastim 624Cytarabine 587Nivolumab 586Leucovorin 583Vincristine 517Cetuximab 479Prednisone 478Bortezomib 474Trastuzumab 468Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 444Lenalidomide 436

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × enadenotucirev × Clear all
NCT03916510 2025-02-06

CEDAR

University of Oxford

Phase 1 Completed
12 enrolled 13 charts
Gastrointestinal

Adenoviridae Infections, Rectal Neoplasms

NCT02636036 2021-11-09

SPICE

Akamis Bio

Phase 1 Completed
51 enrolled
GastrointestinalHead & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Neoplasm Metastasis, Colorectal Neoplasms

NCT02028117 2021-05-13

OCTAVE

Akamis Bio

Phase 1 Completed
38 enrolled
Gynecologic

Recurrent Platinum Resistant Ovarian Cancer

NCT02028442 2020-03-12

EVOLVE

Akamis Bio

Phase 1/2 Completed
61 enrolled
GastrointestinalGenitourinary

Urinary Bladder Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡